FDA grapples with gray areas in fast-tracking experimental drugs
Gray areas create agonizing conundrums for agency officials and patient advocates.
Experimental Ebola treatment given to Americans, but when will regulatory pathway extend to sick Africans?
The two Ebola-infected Americans recently evacuated from Liberia were given an experimental drug that probably saved their lives, but Popular Science raises an interesting point – no Africans are likely to get the same treatment. Not anytime soon, that is. Kent Brantly and Nancy Writebol, the two volunteers in an Ebola clinic that contracted the deadly virus, […]
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.